Editorial
doi: 10.1016/j.jbspin.2018.03.002.
Epub 2018 Mar 21.
Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)
Affiliations
- PMID: 29574143
- DOI: 10.1016/j.jbspin.2018.03.002
Item in Clipboard
Editorial
Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)
Joint Bone Spine.
2018 Jul.
No abstract available
Keywords: Biologics; Biosimilars; Cost containment; Extrapolation; Interchangeability; Substitution.
Comment in
-
Biosimilars: complements and comments on the recent statement of the SFR and CRI. Comment on: "Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)." Schaeverbeke et al. Joint Bone Spine 2018;95:399-402.Joint Bone Spine. 2019 Mar;86(2):287-288. doi: 10.1016/j.jbspin.2018.10.009. Epub 2018 Oct 27. Joint Bone Spine. 2019. PMID: 30394338 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
